| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.68 | 7e-05 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |